242 related articles for article (PubMed ID: 20830690)
81. ΔNp63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
Zhao W; Wang H; Peng Y; Tian B; Peng L; Zhang DC
Int J Clin Exp Pathol; 2014; 7(7):4247-53. PubMed ID: 25120805
[TBL] [Abstract][Full Text] [Related]
82. Cytologic and histopathologic diagnosis in bronchopulmonary squamous cell carcinoma.
Drăgan AM; Roşca E; Muţiu G
Rom J Morphol Embryol; 2011; 52(1 Suppl):395-8. PubMed ID: 21424081
[TBL] [Abstract][Full Text] [Related]
83. GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.
Wang LJ; Greaves WO; Sabo E; Noble L; Tavares R; Ng T; DeLellis RA; Resnick MB
Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):505-11. PubMed ID: 19620839
[TBL] [Abstract][Full Text] [Related]
84. TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.
Aulakh KS; Chisholm CD; Smith DA; Speights VO
Arch Pathol Lab Med; 2013 Aug; 137(8):1094-8. PubMed ID: 23899066
[TBL] [Abstract][Full Text] [Related]
85. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids.
Afify AM; al-Khafaji BM
Acta Cytol; 2002; 46(4):675-8. PubMed ID: 12146029
[TBL] [Abstract][Full Text] [Related]
86. Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas.
Cadioli A; Rossi G; Costantini M; Cavazza A; Migaldi M; Colby TV
Am J Surg Pathol; 2014 Apr; 38(4):502-9. PubMed ID: 24441660
[TBL] [Abstract][Full Text] [Related]
87. The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
Kandalaft PL; Gown AM; Isacson C
Am J Clin Pathol; 2014 Dec; 142(6):830-6. PubMed ID: 25389337
[TBL] [Abstract][Full Text] [Related]
88. TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Porcel JM; Palma R; Bielsa S; Esquerda A; Gatius S; Matias-Guiu X; Salud A
Respirology; 2015 Jul; 20(5):831-3. PubMed ID: 25873201
[TBL] [Abstract][Full Text] [Related]
89. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
Ao MH; Zhang H; Sakowski L; Sharma R; Illei PB; Gabrielson E; Askin F; Li QK
Hum Pathol; 2014 May; 45(5):926-34. PubMed ID: 24746197
[TBL] [Abstract][Full Text] [Related]
90. [Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
Zhang B; Lin J; Da J
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):499-503. PubMed ID: 26705042
[TBL] [Abstract][Full Text] [Related]
91. The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.
Li L; Li X; Yin J; Song X; Chen X; Feng J; Gao H; Liu L; Wei S
PLoS One; 2014; 9(7):e100837. PubMed ID: 25003505
[TBL] [Abstract][Full Text] [Related]
92. Exophytic mass of the gingiva as the first manifestation of metastatic pulmonary adenocarcinoma.
Pozzi EC; Altermatt HJ; Rees TD; Bornstein MM
J Periodontol; 2008 Jan; 79(1):187-91. PubMed ID: 18166110
[TBL] [Abstract][Full Text] [Related]
93. Thyroid transcription factor 1 in pulmonary adenocarcinoma.
Stenhouse G; Fyfe N; King G; Chapman A; Kerr KM
J Clin Pathol; 2004 Apr; 57(4):383-7. PubMed ID: 15047742
[TBL] [Abstract][Full Text] [Related]
94. [Clinicopathological and prognostic significance of a panel of tumor biomarkers in lung adenocarcinoma: a tissue microarray study].
Yang X; Xue L; Guo L; Wen P; Lin D
Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):243-53. PubMed ID: 24667263
[TBL] [Abstract][Full Text] [Related]
95. ALK/EML4 fusion gene may be found in pure squamous carcinoma of the lung.
Caliò A; Nottegar A; Gilioli E; Bria E; Pilotto S; Peretti U; Kinspergher S; Simionato F; Pedron S; Knuutila S; Tortora G; Eccher A; Santo A; Tondulli L; Inghirami G; Tabbò F; Martignoni G; Chilosi M; Scarpa A; Brunelli M
J Thorac Oncol; 2014 May; 9(5):729-32. PubMed ID: 24722159
[TBL] [Abstract][Full Text] [Related]
96. Warranting investigation of primary lung adenocarcinoma in patients with an extrapulmonary malignancy and lung nodules due to high frequency.
Zhu B; Dalal S; Kamp DW; Lin X
Am J Clin Pathol; 2014 Mar; 141(3):429-36. PubMed ID: 24515772
[TBL] [Abstract][Full Text] [Related]
97. Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Sharifai N; Abro B; Chen JF; Zhao M; He H; Cao D
Hum Pathol; 2020 Aug; 102():23-32. PubMed ID: 32561332
[TBL] [Abstract][Full Text] [Related]
98. Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.
Zhang P; Han YP; Huang L; Li Q; Ma DL
Oncol Lett; 2010 Sep; 1(5):899-903. PubMed ID: 22966403
[TBL] [Abstract][Full Text] [Related]
99. Immunohistochemical expression of estrogen receptor in pulmonary adenocarcinoma.
Lau SK; Chu PG; Weiss LM
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):83-7. PubMed ID: 16540736
[TBL] [Abstract][Full Text] [Related]
100. Trefoil factor 3 as a novel biomarker to distinguish between adenocarcinoma and squamous cell carcinoma.
Wang XN; Wang SJ; Pandey V; Chen P; Li Q; Wu ZS; Wu Q; Lobie PE
Medicine (Baltimore); 2015 May; 94(20):e860. PubMed ID: 25997063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
